The plant-derived small molecule, tigilanol tiglate targets various solid tumours across multiple species. The drug is being developed as an intratumoural treatment for solid tumours. It has a
The post QBiotics receives IND application approval for Phase II solid tumours therapy trial appeared first on Pharmaceutical Business review.